239 related articles for article (PubMed ID: 24985952)
21. A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism.
Bank N; Su WS; Aynedjian HS
J Clin Invest; 1978 Apr; 61(4):884-94. PubMed ID: 659581
[TBL] [Abstract][Full Text] [Related]
22. Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism.
Carnevale V; Del Fiacco R; Romagnoli E; Fontana A; Cipriani C; Pepe J; Minisola S
Calcif Tissue Int; 2013 Jan; 92(1):15-22. PubMed ID: 23080188
[TBL] [Abstract][Full Text] [Related]
23. A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.
Raposo JF; Pires A; Yokota H; Ferreira HG
Endocrine; 2012 Apr; 41(2):309-19. PubMed ID: 21874319
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
Hirschel-Scholz S; Caverzasio J; Bonjour JP
J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
[TBL] [Abstract][Full Text] [Related]
25. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
Madsen S; Olgaard K
Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
[TBL] [Abstract][Full Text] [Related]
26. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism.
Sørensen HA; Schwarz P; McNair P; Hyldstrup L; Transbøl I
Scand J Clin Lab Invest; 1992 Oct; 52(6):457-65. PubMed ID: 1411258
[TBL] [Abstract][Full Text] [Related]
27. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
28. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
29. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
[TBL] [Abstract][Full Text] [Related]
30. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum.
Peacock M
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N87-94. PubMed ID: 12412783
[TBL] [Abstract][Full Text] [Related]
31. Glomerular filtration rate and parathyroid hormone are associated with 1,25-dihydroxyvitamin D in men without chronic kidney disease.
Karhapää P; Pihlajamäki J; Pörsti I; Kastarinen M; Mustonen J; Niemelä O; Tuomi H; Kuusisto J
J Intern Med; 2012 Jun; 271(6):573-80. PubMed ID: 21995281
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D and Secondary Hyperparathyroid States.
Cipriani C; Pepe J; Colangelo L; Minisola S
Front Horm Res; 2018; 50():138-148. PubMed ID: 29597237
[TBL] [Abstract][Full Text] [Related]
33. Regulation of renal calbindin-D28K.
Hemmingsen C
Pharmacol Toxicol; 2000; 87 Suppl 3():5-30. PubMed ID: 11097107
[TBL] [Abstract][Full Text] [Related]
34. The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.
Farias ML; Delgado AG; Rosenthal D; Vieira JG; Kasamatsu T; Lazarevitch MJ; Pereira MF; Lima MB
J Endocrinol Invest; 1996 Jan; 19(1):12-20. PubMed ID: 8851686
[TBL] [Abstract][Full Text] [Related]
35. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
[TBL] [Abstract][Full Text] [Related]
36. Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective.
Rejnmark L; Ejlsmark-Svensson H
Curr Osteoporos Rep; 2020 Jun; 18(3):103-114. PubMed ID: 32222892
[TBL] [Abstract][Full Text] [Related]
37. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
38. [Frontiers in vitamin D; basic research and clinical application. Vitamin D and secondary hyperparathyroidism].
Tanaka H; Komaba H; Fukagawa M
Clin Calcium; 2011 Nov; 21(11):27-34. PubMed ID: 22040818
[TBL] [Abstract][Full Text] [Related]
39. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism.
Bortotolotto LA; Costa-Hong V; Jorgetti V; Consolim-Colombo F; Rosa K; Silva BC; Krieger EM; De Lima JJ
J Nephrol; 2007; 20(1):66-72. PubMed ID: 17347976
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?
Brown AJ
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):578-83. PubMed ID: 17368185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
